As part of its advocacy program in the United States, ACRO submits regulatory comments to US regulators. This comment letter, submitted by ACRO to HHS and OCR in 2019 about Request for Information, RIN 0945-AA00 – HIPAA Rules and recommendation to facilitate the use of PHI for essential research can be found below.